Zydus Gets US FDA Approval for Estradiol Patch
Zydus Lifesciences has received the US FDA approval for Estradiol and Levonorgestrel Transdermal System, eligible for 180-day CGT exclusivity.
Zydus Lifesciences | 21/10/2026 | By News Bureau | 120
FYB206 Becomes First Keytruda Biosimilar to Get US FDA Review
The US FDA has accepted FYB206’s Biologics License Application (BLA) for review, marking the first publicly announced Keytruda biosimilar filing acceptance.
Zydus Lifesciences | 13/10/2026 | By News Bureau | 108
Zydus and MSN Launch First Generic Adempas in US
Zydus and MSN has launched the first generic Adempas (riociguat) in the US, offering a lower-cost treatment for pulmonary hypertension patients.
Zydus Lifesciences | 06/10/2026 | By News Bureau
Zydus Lifesciences Reports 22 Percent Revenue Growth in Q1 FY27, Advances Innovation Pipeline
Zydus Lifesciences began FY27 with strong double-digit growth, driven by robust performance across India and international formulations, alongside continued progress in manufacturing quality and biosimilar innovation.
Zydus Lifesciences | 12/08/2026 | By News Bureau | 139
Zydus Launches REVAHALE, India's First Once-Daily Nebulised LAMA for COPD
Zydus launches REVAHALE (revefenacin), India’s first once-daily nebulised LAMA for COPD, offering sustained 24-hour bronchodilation through nebulised delivery.
Zydus Lifesciences | 11/08/2026 | By News Bureau | 102
Zydus Wins US FDA Approval for Generic Indocyanine Green Injection
Zydus has received US Food and Drug Administration (FDA) approval for generic Indocyanine Green Injection, expanding its injectable imaging portfolio and functional dyes business.
Zydus Lifesciences | 06/08/2026 | By News Bureau | 201
Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue
Torrent Pharmaceuticals has initiated a recall of select batches of Semalix Injection 2 mg and 4 mg after certain semaglutide batches failed quality specifications due to an API-related issue.
Zydus Lifesciences | 10/07/2026 | By News Bureau | 293
Zydus Lifesciences and Sunshine Healthcare Form JV to Boost Pharma Manufacturing in Sri Lanka
Zydus Lifesciences and Sunshine Healthcare launch a Joint Venture (JV) to develop a pharma manufacturing facility at BOI Horana, strengthening Sri Lanka’s supply of quality medicines.
Zydus Lifesciences | 29/06/2026 | By News Bureau | 247
Assertio Announces Completion of Merger with Zydus Lifesciences
Assertio has completed its merger with Zydus Lifesciences, becoming a wholly owned subsidiary of the company. Following the acquisition, Assertio shares have been delisted from Nasdaq, with shareholders receiving USD 23.50 per share in cash.
Zydus Lifesciences | 19/06/2026 | By News Bureau | 190
US FDA Grants Priority Review to Zydus Therapeutics' Saroglitazar for Primary Biliary Cholangitis
Zydus Therapeutics has received US FDA Priority Review (PR) for its New Drug Application (NDA) for saroglitazar in the treatment of Primary Biliary Cholangitis (PBC), supported by phase 3 EPICS-III trial results demonstrating significant biochemical response, with detailed data to be presented at the EASL Congress 2026.
Zydus Lifesciences | 29/05/2026 | By News Bureau | 311
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy